» Articles » PMID: 19462257

Gene Expression Profiles in the PC-3 Human Prostate Cancer Cells Induced by NKX3.1

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2009 May 23
PMID 19462257
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

NKX3.1, a prostate-specific gene, plays an important role in prostate development and carcinogenesis. However, its precise function has not been established. In present study, we transfected the NKX3.1 eukaryotic expression plasmid (pcDNA3.1-NKX3.1) into human prostate cancer cells PC-3, which lack of NKX3.1 expression, and established stable transfectants. Then, we investigated the influence of NKX3.1 on the cell growth, cell migration and colony formation efficiency. The results showed that restoration of NKX3.1 expression inhibited proliferation and invasion activities of PC-3 cells. Further, a cDNA microarray containing 22,000 human genes was used to identify the gene expression differences. The results showed that there were 1,953 genes showing more than a two-fold difference in expression. Subsequent ontological analysis revealed that a large proportion of the classified genes were related to cell growth, cell signal and cell invasion. Finally, the expression of Caspase-3, Bcl-2, P27, Cdk6 and AMACR, randomly selected genes from microarray data, was validated by RT-PCR and western blot. Collectively, our results first analyzed the gene expression profile in PC-3 cells induced by NKX3.1 and indicated that NKX3.1 might exert its function by regulating the expression of relative genes.

Citing Articles

The Role of Nkx3.1 in Cancers and Stemness.

Antao A, Ramakrishna S, Kim K Int J Stem Cells. 2021; 14(2):168-179.

PMID: 33632988 PMC: 8138659. DOI: 10.15283/ijsc20121.


RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.

Logan M, Anderson P, Saab S, Hameed O, Abdulkadir S Am J Pathol. 2013; 183(3):951-63.

PMID: 23867798 PMC: 3763771. DOI: 10.1016/j.ajpath.2013.05.021.


The inhibitory effects of NKX3.1 on IGF-1R expression and its signalling pathway in human prostatic carcinoma PC3 cells.

Zhang P, Hu X, Liu C, Chen Z, Ni N, Yu Y Asian J Androl. 2011; 14(3):493-8.

PMID: 22179513 PMC: 3720174. DOI: 10.1038/aja.2011.158.


Cancer biomarker discovery: the entropic hallmark.

Berretta R, Moscato P PLoS One. 2010; 5(8):e12262.

PMID: 20805891 PMC: 2923618. DOI: 10.1371/journal.pone.0012262.


Luteolin suppresses growth and migration of human lung cancer cells.

Zhao Y, Yang G, Ren D, Zhang X, Yin Q, Sun X Mol Biol Rep. 2010; 38(2):1115-9.

PMID: 20589534 DOI: 10.1007/s11033-010-0208-x.


References
1.
Chesire D, Ewing C, Gage W, Isaacs W . In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis. Oncogene. 2002; 21(17):2679-94. DOI: 10.1038/sj.onc.1205352. View

2.
Katoh M . Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer. Int J Oncol. 2001; 19(5):1003-7. DOI: 10.3892/ijo.19.5.1003. View

3.
Glinsky G, Glinskii A, Stephenson A, Hoffman R, Gerald W . Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest. 2004; 113(6):913-23. PMC: 362118. DOI: 10.1172/JCI20032. View

4.
Chesire D, Ewing C, Sauvageot J, Bova G, Isaacs W . Detection and analysis of beta-catenin mutations in prostate cancer. Prostate. 2000; 45(4):323-34. DOI: 10.1002/1097-0045(20001201)45:4<323::aid-pros7>3.0.co;2-w. View

5.
Chen H, Nandi A, Li X, Bieberich C . NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter. Cancer Res. 2002; 62(2):338-40. View